Rapid Micro Biosystems (Rapid Micro Biosystems) EV-to-Revenue : -1.62 (As of May. 17, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Rapid Micro Biosystems EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Rapid Micro Biosystems's enterprise value is $-37.32 Mil. Rapid Micro Biosystems's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $23.10 Mil. Therefore, Rapid Micro Biosystems's EV-to-Revenue for today is -1.62.

The historical rank and industry rank for Rapid Micro Biosystems's EV-to-Revenue or its related term are showing as below:

RPID' s EV-to-Revenue Range Over the Past 10 Years
Min: -3.26 Med: -1.47 Max: 50.57
Current: -1.62

During the past 5 years, the highest EV-to-Revenue of Rapid Micro Biosystems was 50.57. The lowest was -3.26. And the median was -1.47.

RPID's EV-to-Revenue is ranked better than
98.43% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: 3.28 vs RPID: -1.62

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-17), Rapid Micro Biosystems's stock price is $0.82. Rapid Micro Biosystems's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.54. Therefore, Rapid Micro Biosystems's PS Ratio for today is 1.53.

Rapid Micro Biosystems EV-to-Revenue Historical Data

The historical data trend for Rapid Micro Biosystems's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Micro Biosystems EV-to-Revenue Chart

Rapid Micro Biosystems Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

10.66

-3.10

-2.37

Rapid Micro Biosystems Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial													-2.03	-2.94	-1.76	-2.37	-1.34

Competitive Comparison of Rapid Micro Biosystems's EV-to-Revenue

For the Medical Devices subindustry, Rapid Micro Biosystems's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Micro Biosystems's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rapid Micro Biosystems's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Rapid Micro Biosystems's EV-to-Revenue falls into.

Rapid Micro Biosystems EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Rapid Micro Biosystems's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-37.320	/	23.095
	=	-1.62

Rapid Micro Biosystems's current Enterprise Value is $-37.32 Mil.
Rapid Micro Biosystems's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.10 Mil.

Rapid Micro Biosystems (NAS:RPID) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Rapid Micro Biosystems's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.82	/	0.536
	=	1.53

Rapid Micro Biosystems's share price for today is $0.82.
Rapid Micro Biosystems's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.54.

Rapid Micro Biosystems EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rapid Micro Biosystems's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Micro Biosystems (Rapid Micro Biosystems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rapid Micro Biosystems Inc (NAS:RPID) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Pawtucket Boulevard West, Suite 280, Lowell, MA, USA, 01854

Website

https://www.rapidmicrobio.com

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Executives

Sean M Wirtjes	officer: Chief Financial Officer	C/O VARIAN, INC., 3120 HANSEN WAY, M/S D-083, PALO ALTO CA 94304-1030
Spignesi Robert G. Jr.	director, officer: President and CEO	C/O RAPID MICRO BIOSYSTEMS, INC., 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854
Kirk Malloy	director	5200 ILLUMINA WAY, SAN DIEGO CA 92122
Kennedy Lewis Capital Partners Master Fund Ii Lp	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Klm Gp Llc	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Kennedy Lewis Capital Partners Master Fund Iii Lp	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Gp Ii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Gp Iii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Investment Holdings Ii Llc	10 percent owner	111 WEST 33RD STREET, SUITE 1910, NEW YORK NY 10120
Kennedy Lewis Investment Management Llc	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Kennedy Lewis Management Lp	10 percent owner	225 LIBERTY STREET, SUITE 4210, NEW YORK NY 10281
David Chene	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Darren Richman	10 percent owner	80 BROAD STREET, 22ND FLOOR, NEW YORK NY 10004
Inese Lowenstein	director	C/O RAPID MICRO BIOSYSTEMS INC, 1001 PAWTUCKET BOULEVARD WEST, SUITE 280, LOWELL MA 01854
Richard A Keys	officer: CHIEF COMMERCIAL OFFICER	C/O RAPID MICRO BIOSYSTEMS INC, 1001 PAWTUCKET BOULEVARD, SUITE 280, LOWELL MA 01854